Peer-reviewedCC BY-NC-NDTranslational cancer research
Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
Related
- A Systematic Review and Meta-Analysis: Does Molecular Hydrogen Exert Radioprotective Effects Without Compromising the Antitumor Efficacy of Radiotherapy or Concurrent Chemoradiotherapy?
- Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG‐rhG‐CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
- Rapid disease progression during adjuvant chemotherapy following concurrent chemoradiotherapy and radical resection for rectal sarcomatoid carcinoma: a case report and literature review
- Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
- Distinct prognostic impact of circumferential resection margin and adverse histologic features after intersphincteric resection for ultra-low rectal cancer following chemoradiotherapy: a retrospective cohort study.
BibTeX
@article{anon2026sequential,
title = {{Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study}},
journal = {Translational cancer research},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13657821},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Sequential chemoradiotherapy vs. radiotherapy alone or concurrent chemoradiotherapy after radical resection of stage IA2–IIA1 cervical cancer: a retrospective cohort study
PY - 2026
DA - 2026/09/19
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657821
SN - 2218-676X
ER -